NCT04434040 · Interventional trial
Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
Overall registry status Recruiting
Phase 2
Conditions Breast Cancer, Circulating Tumor DNA, Residual Cancer, Triple Negative Breast Cancer
Delaware Valley sites
- University of Pennsylvania-Abramson Cancer Center · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory